Chicago, ILNCT07433023Now EnrollingIRB Ready

Cerebral Palsy Clinical Trial in Chicago, IL

Access cutting-edge cerebral palsy treatment through this phase 2 clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by Shirley Ryan AbilityLab

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access cerebral palsy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cerebral palsy treatment provided free

Apply for This Chicago Location

Check if you qualify for this cerebral palsy clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Cerebral Palsy Study in Chicago

This is an intervention study to investigate the impact of spinal stimulation on mobility outcomes in children with Cerebral Palsy. Participants will complete a 16-week training program with weekly sessions of spinal stimulation and walking or activity-based training. Participants will also have the option to participate in a randomized control trial to investigate the impact of 5-Azacitidine combined with the spinal stimulation to further affect mobility outcomes.

Sponsor: Shirley Ryan AbilityLab

Who Can Participate

Inclusion Criteria

Diagnosis of cerebral palsy (CP) classified as Gross Motor Function Classification System (GMFCS) Levels I-V.
Between 4 and 17 years old at the time of enrollment/consent.
Diagnosis of spastic CP hemiplegia, diplegia, or quadriplegia.
Stable medical condition as determined by the investigator.
Adequate caregiver support to be able to participate in training and assessment sessions for the duration of the study, at the discretion of the Investigator.
Capable of performing simple cued motor tasks and can follow 2-3 step commands.
Capable of communicating an accurate yes or no answer to questions according to parent or guardian.
Able to localize pain/ discomfort.
Physician approval for participation.
Parent/ guardian permission.

Exclusion Criteria

Concurrent neurological disease affecting the central nervous system.
Cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention
Orthopedic dysfunction, injury, or surgery that would impact an individual's ability to use the upper and/or lower extremity
Unhealed fracture or other musculoskeletal impairment that might interfere with upper or lower extremity rehabilitation or testing activities
Implanted stimulator (e.g., epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant) or drug delivery device (e.g., baclofen pump)
Dependence on an electro-magnetic medical implant (e.g., cardiac pacemaker, implanted drug pump), ventilation support, or another external device.
History of uncontrolled seizures
Unexplained presence of persistent complaints of pain of any kind
Unable to localize pain/discomfort
Severe cortico-visual impairment
Active pressure sores
Active urinary tract infection
Active cancer or cancer in remission less than 5 years
Clinically significant depression, psychiatric disorders, or ongoing drug abuse
Immunodeficiency or hematologic condition
Allergy to AZA or mannitol
Plans to receive a vaccine within 30 days of the planned AZA or placebo injection to take place at week 10
Orthopedic surgery completed in the prior 12 months
Intrathecal medication titration that may affect muscle spasticity
Botulinum toxin treatment within 3 months preceding enrollment unless given approval by the treating physician
Current enrollment in a conflicting research study
Any other health condition or diagnosis not listed above that may put the participant at risk as determined by the investigator or treating physician

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT07433023) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cerebral Palsy Treatment Options in Chicago, IL

If you're searching for cerebral palsy treatment options in Chicago, IL, this clinical trial (NCT07433023) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced cerebral palsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cerebral palsy clinical trials near you to find additional studies recruiting in your area.

More ALS Trials in Chicago, IL

See all als clinical trials recruiting in Chicago — not just this study.

Browse ALS Trials in Chicago →

Browse More Trials by Condition

ALS TrialsRheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL